Xiang-Xi Xu Selected Research

GATA Transcription Factors

7/2009	Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia.
3/2008	GATA-4 and GATA-6 expression in human ovarian surface epithelial carcinoma.
8/2003	Anomalous expression of epithelial differentiation-determining GATA factors in ovarian tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiang-Xi Xu Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 05/2002
16	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 02/2004
5	Aneuploidy (Aneuploid) 01/2018 - 09/2009
5	Carcinogenesis 07/2009 - 08/2003
5	Carcinoma (Carcinomatosis) 03/2008 - 10/2002
2	Breast Neoplasms (Breast Cancer) 09/2021 - 06/2011
2	Tetraploidy 01/2018 - 11/2016
2	Metrorrhagia (Spotting) 01/2015 - 05/2012
2	Vesicular Stomatitis 12/2011 - 02/2010
2	Adenoma (Adenomas) 02/2010 - 05/2002
2	Ovarian Epithelial Carcinoma 02/2010 - 10/2003
2	Neoplasm Metastasis (Metastasis) 02/2007 - 10/2002
2	Cysts 12/2003 - 10/2002
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Alopecia (Baldness) 01/2022
1	Neutropenia 01/2022
1	Shock 09/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2021
1	Chronic Renal Insufficiency 11/2018
1	Rupture 01/2018
1	Protein Deficiency 01/2017
1	Infections 02/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2016
1	Chromosomal Instability (Chromosome Stability) 02/2016
1	Hypercholesterolemia 01/2016
1	Atherosclerosis 01/2016
1	Atherosclerotic Plaque (Atheroma) 01/2016
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Poisoning 05/2012
1	Polyploidy 09/2009
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 07/2009
1	Leukemia 05/2002
1	Lung Neoplasms (Lung Cancer) 05/2002

Drug/Important Bio-Agent (IBA)

9	Lamin Type A (Lamin A)IBA 01/2021 - 03/2011
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2002
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2021
3	taxaneIBA 01/2022 - 01/2021
3	Pharmaceutical PreparationsIBA 09/2021 - 02/2010
3	Small Interfering RNA (siRNA)IBA 03/2011 - 09/2009
3	GATA Transcription FactorsIBA 07/2009 - 08/2003
3	GonadotropinsIBA 11/2008 - 10/2003
2	PlatinumIBA 01/2022 - 01/2021
2	Docetaxel (Taxotere)FDA Link 01/2022 - 01/2021
2	emerinIBA 01/2017 - 09/2009
2	Indicators and Reagents (Reagents)IBA 02/2016 - 03/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2007 - 12/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2005 - 02/2004
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2004 - 10/2002
2	Laminin (Merosin)IBA 10/2002 - 05/2002
2	CollagenIBA 10/2002 - 05/2002
1	AntidotesIBA 01/2022
1	Taxoids (Taxanes)IBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 09/2021
1	Excipients (Suspending Agents)IBA 01/2021
1	Waste Products (Waste Product)IBA 11/2018
1	Caspase 6IBA 01/2018
1	Histone Deacetylase InhibitorsIBA 02/2016
1	A 17 (A-17)IBA 02/2016
1	Protein Kinase InhibitorsIBA 02/2016
1	StaurosporineIBA 02/2016
1	CholesterolIBA 01/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2015
1	Biological ProductsIBA 01/2014
1	Complement System Proteins (Complement)IBA 01/2014
1	saracatinibIBA 11/2012
1	Fulvestrant (Faslodex)FDA Link 11/2012
1	Estrogens (Estrogen)FDA Link 11/2012
1	Estrogen Receptor Modulators (Antiestrogen)IBA 11/2012
1	Estrogen ReceptorsIBA 11/2012
1	Phosphotransferases (Kinase)IBA 05/2012
1	LaminsIBA 06/2011
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 02/2010
1	AntigensIBA 02/2010
1	GATA6 Transcription FactorIBA 09/2009
1	ChromatinIBA 07/2009
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2008
1	Cyclooxygenase InhibitorsIBA 04/2007
1	Matrix Metalloproteinases (MMPs)IBA 02/2007
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2007
1	Matrix Metalloproteinase InhibitorsIBA 02/2007
1	Metalloproteases (Metalloproteinases)IBA 02/2007
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2007
1	Peptide Hydrolases (Proteases)FDA Link 02/2004
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2004
1	Messenger RNA (mRNA)IBA 05/2002

Therapy/Procedure

5	Therapeutics 01/2021 - 02/2010
5	Ovariectomy (Oophorectomy) 05/2012 - 12/2003
2	Drug Therapy (Chemotherapy) 01/2022 - 09/2021
1	Salvage Therapy 09/2021
1	Chemoprevention 01/2004
1	Aftercare (After-Treatment) 05/2002